Evidence map›Paper›PMID 35016602›Full record

ArticleBMC bioinformatics2022

Predicting combinations of drugs by exploiting graph embedding of heterogeneous networks.

Fei Song, Shiyin Tan, Zengfa Dou, Xiaogang Liu, Xiaoke Ma

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Fei Song *School of Computer Science and Technology, Xidian University, No. 2 South TaiBai Road, 710071, Xi'an, People's Republic of China.
Shiyin Tan *School of Computer Science and Technology, Xidian University, No. 2 South TaiBai Road, 710071, Xi'an, People's Republic of China.
Zengfa Dou *The 20-th Research Institute, China Electronics Technology Group Corporation, Guanhua Road, 710071, Xi'an, People's Republic of China.
Xiaogang LiuSchool of Mathematics and Statistics, Northwestern Polytechnical University, No. 1 Dongxiang Road, 710072, Xi'an, People's Republic of China. xiaogliu@nwpu.edu.cn.
Xiaoke MaSchool of Computer Science and Technology, Xidian University, No. 2 South TaiBai Road, 710071, Xi'an, People's Republic of China. xkma@xidian.edu.cn.
Xidian University · CNChina Electronics Technology Group Corporation · CNNorthwestern Polytechnical University · CN

Funding

Key Research and Development Program of Gansu 21YF5GA063Natural Science Foundation of Qinghai 2020-ZJ-920NFSC 11601431NFSC 61772394
6 · The paper itself

Abstract

backgroundDrug combination, offering an insight into the increased therapeutic efficacy and reduced toxicity, plays an essential role in the therapy of many complex diseases. Although significant efforts have been devoted to the identification of drugs, the identification of drug combination is still a challenge. The current algorithms assume that the independence of feature selection and drug prediction procedures, which may result in an undesirable performance.

resultsTo address this issue, we develop a novel Semi-supervised Heterogeneous Network Embedding algorithm (called SeHNE) to predict the combination patterns of drugs by exploiting the graph embedding. Specifically, the ATC similarity of drugs, drug-target, and protein-protein interaction networks are integrated to construct the heterogeneous networks. Then, SeHNE jointly learns drug features by exploiting the topological structure of heterogeneous networks and predicting drug combination. One distinct advantage of SeHNE is that features of drugs are extracted under the guidance of classification, which improves the quality of features, thereby enhancing the performance of prediction of drugs. Experimental results demonstrate that the proposed algorithm is more accurate than state-of-the-art methods on various data, implying that the joint learning is promising for the identification of drug combination.

conclusionsThe proposed model and algorithm provide an effective strategy for the prediction of combinatorial patterns of drugs, implying that the graph-based drug prediction is promising for the discovery of drugs.

Indexed as

AlgorithmsProtein Interaction MapsDrug CombinationsLearningDrug CombinationsDrug combinationGraph embeddingHeterogeneous networkJoint learning

Identifiers

PMID35016602
PMCPMC8753820
OpenAlexW4205304785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.